reviewFrontiers in PharmacologyJan 19, 2022GOLD OA

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis

Huazhong University of Science and Technology

PubMed
Indexed incrossrefdoajpubmed

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal fibrotic lung disease that occurs primarily in middle-aged and elderly adults. It is a major cause of morbidity and mortality. With an increase in life expectancy, the economic burden of IPF is expected to continuously rise in the near future. Although the exact pathophysiological mechanisms underlying IPF remain not known. Significant progress has been made in our understanding of the pathogenesis of this devastating disease in last decade. The current paradigm assumes that IPF results from sustained or repetitive lung epithelial injury and subsequent activation of fibroblasts and myofibroblast differentiation. Persistent myofibroblast phenotype…

No related works found for this paper.

Funding